These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16611102)

  • 1. Patients with Hereditary Hemorrhagic Telangectasia (HHT) exhibit a deficit of polymorphonuclear cell and monocyte oxidative burst and phagocytosis: a possible correlation with altered adaptive immune responsiveness in HHT.
    Cirulli A; Loria MP; Dambra P; Di Serio F; Ventura MT; Amati L; Jirillo E; Sabbà C
    Curr Pharm Des; 2006; 12(10):1209-15. PubMed ID: 16611102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological abnormalities associated with hereditary haemorrhagic telangiectasia.
    Guilhem A; Malcus C; Clarivet B; Plauchu H; Dupuis-Girod S
    J Intern Med; 2013 Oct; 274(4):351-62. PubMed ID: 23772771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary haemorrhagic telangiectasia: a rare disease as a model for the study of human atherosclerosis.
    Lenato GM; Suppressa P; Giordano P; Guanti G; Guastamacchia E; Triggiani V; Amati L; Resta F; Covelli V; Jirillo E; Sabbà C
    Curr Pharm Des; 2007; 13(36):3656-64. PubMed ID: 18220803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablation of T-helper 1 cell derived cytokines and of monocyte-derived tumor necrosis factor-alpha in hereditary hemorrhagic telangiectasia: immunological consequences and clinical considerations.
    Amati L; Passeri ME; Resta F; Triggiani V; Jirillo E; Sabbà C
    Curr Pharm Des; 2006; 12(10):1201-8. PubMed ID: 16611101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
    Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
    BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expressions of CXCR4 and CD26 on T-helper lymphocytes in hereditary hemorrhagic telangiectasia.
    Guilhem A; Portalès P; Dupuis-Girod S; Rivière S; Vincent T
    Orphanet J Rare Dis; 2021 Dec; 16(1):511. PubMed ID: 34906163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the transforming growth factor beta in the pathogenesis of hereditary hemorrhagic telangiectasia.
    Jirillo E; Amati L; Suppressa P; Cirimele D; Guastamacchia E; Covelli V; Tafaro E; Sabbà C
    Curr Pharm Des; 2006; 12(10):1195-200. PubMed ID: 16611100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immune mechanisms in the pathogenesis of systemic lupus erythematosus (SLE).
    de la Fuente H; Richaud-Patin Y; Jakez-Ocampo J; González-Amaro R; Llorente L
    Immunol Lett; 2001 Jul; 77(3):175-80. PubMed ID: 11410251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression.
    Sadick H; Riedel F; Naim R; Goessler U; Hörmann K; Hafner M; Lux A
    Haematologica; 2005 Jun; 90(6):818-28. PubMed ID: 15951295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunction of Circulating Polymorphonuclear Leukocytes and Monocytes in Ambulatory Cirrhotics Predicts Patient Outcome.
    Sargenti K; Johansson Å; Bertilsson S; Mattsby-Baltzer I; Klintman D; Kalaitzakis E
    Dig Dis Sci; 2016 Aug; 61(8):2294-2302. PubMed ID: 27010544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke alters respiratory burst in neutrophils and monocytes.
    Ruhnau J; Schulze K; Gaida B; Langner S; Kessler C; Bröker B; Dressel A; Vogelgesang A
    Stroke; 2014 Mar; 45(3):794-800. PubMed ID: 24523038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hepatitis B virus e antigen suppresses the respiratory burst and mobility of human monocytes and neutrophils.
    Leu CM; Lu YC; Peng WL; Chu HT; Hu CP
    Immunobiology; 2014 Nov; 219(11):880-7. PubMed ID: 25123430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.
    Abdalla SA; Letarte M
    J Med Genet; 2006 Feb; 43(2):97-110. PubMed ID: 15879500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1.
    Wallace GM; Shovlin CL
    Thorax; 2000 Aug; 55(8):685-90. PubMed ID: 10899246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1.
    Letarte M; McDonald ML; Li C; Kathirkamathamby K; Vera S; Pece-Barbara N; Kumar S
    Cardiovasc Res; 2005 Oct; 68(1):155-64. PubMed ID: 15907823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global gene expression profiling of telangiectasial tissue from patients with hereditary hemorrhagic telangiectasia.
    Tørring PM; Larsen MJ; Kjeldsen AD; Ousager LB; Tan Q; Brusgaard K
    Microvasc Res; 2015 May; 99():118-26. PubMed ID: 25892364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis in Spanish patients with hereditary hemorrhagic telangiectasia: deficient endoglin up-regulation in activated monocytes.
    Sanz-Rodriguez F; Fernandez-L A; Zarrabeitia R; Perez-Molino A; Ramírez JR; Coto E; Bernabeu C; Botella LM
    Clin Chem; 2004 Nov; 50(11):2003-11. PubMed ID: 15375013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells.
    Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Ramirez JR; Morales-Angulo C; Zarrabeitia R; Perez-Molino A; Bernabéu C; Botella LM
    Thromb Haemost; 2007 Feb; 97(2):254-62. PubMed ID: 17264955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired phagocytosis and reactive oxygen species production in phagocytes is associated with systemic vasculitis.
    Johansson ÅC; Ohlsson S; Pettersson Å; Bengtsson AA; Selga D; Hansson M; Hellmark T
    Arthritis Res Ther; 2016 Apr; 18():92. PubMed ID: 27102815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss-of-Function in SMAD4 Might Not Be Critical for Human Natural Killer Cell Responsiveness to TGF-β.
    Healy LP; Rossi GR; Rautela J; Slade CA; Huntington ND; Winship IM; Souza-Fonseca-Guimaraes F
    Front Immunol; 2019; 10():904. PubMed ID: 31118932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.